Category Finance

Antigua Creating Platform To Monetise Suspended US IP Rights From WTO Case

The government of Antigua and Barbuda is said to be taking steps to set up a platform to allow the tiny Caribbean nation to monetise or otherwise take advantage of the suspension of US intellectual property rights, as it is permitted to do by a World Trade Organization dispute panel. The WTO panel had ruled that Antigua could make up its loss in IP rights for US measures blocking Antiguan online gambling in the US.

IP Scores High In Sports – Supports Amateurs, Olympics, Development, Speakers Say

Alongside last week’s meeting of the World Trade Organization intellectual property committee, the United States, European Union and Jamaica organised an event on the relevance of intellectual property in sports. Speakers from professional organisations such as the International Olympic Committee, the Association of European Professional Football Leagues, and the Nike company were invited to share their experience in the matter.

GAVI: Reducing Prices To Immunise 250 Million Children By 2015

The GAVI Alliance launched a mid-term report this week showing that the public-private partnership is on track to immunise more than 250 million children by 2015 and prevent some four million deaths. GAVI’s CEO said it uses multiple tools to help reduce prices of vaccine and that intellectual property rights do not pose a serious threat to its success.

WHO Fine-Tuning Pandemic Flu Preparedness Strategy, Use Of Industry Contributions

The World Health Organization is putting the finishing touches on an implementation plan for industry's financial participation in the global influenza preparedness strategy. This week the advisory group met to discuss a draft plan presented by the WHO secretariat, which should now come up with a revised version for implementation in early 2014, according to the chair of the advisory group.

IP Law Europe Summit To Address Patent Policy, Secrecy, Know-How, M&As, Brands Online

IP Law Summit
November 17-19, 2013| Grande Real Villa Itália| Cascais, Lisbon, Portugal

The IP Law Europe Summit is the premium forum bringing together leading in-house IP counsel with specialist international law firms, IP attorneys and legal services providers. As an invitation-only event taking place behind closed doors, the summit offers regional IP executives an intimate environment for a focused discussion of key new drivers shaping the IP industry.

Distinguished speakers include:

Tommi Lehtinen, Head of IPR, Product Differentiation Portfolio, Nokia Siemens Networks
Peter Schøtt Knudsen, VP, Global Head of Legal & IPR, ECCO
Cheree Johnson, Chief Innovation Counsel, HJ Heinz
Jean Luc Chalhoub, GC, New Business & Strategic Partnerships, Orange
Jan Strzebniok, VP & GC, EMEAI, Honeywell Aerospace
Vincent Pickering, CLO & Secretary, WABCO
Mark Lágler, GC, Supply Chain and Global Services, Unilever

Key issues for 2013 include:

Ahead of the Game – Keeping pace with the latest developments in patent legislation in the EU and US
Dynamic Exchange – Leveraging know-how and technology transfer to stimulate cost-efficient innovation
Positive-Sum Game – Informing the M&A strategy to unlock valuable transactions
Secrecy Status – Exploring trade secrets protection to keep expenditure under control and defend IP in fast-moving markets
A Taxing Issue – Orchestrating IP and R&D activities to reap the benefits of favourable tax regimes
Designing Value – Shielding design and packaging elements to boost brand recognition
Diversity Powerhouse – Mastering the art of orchestrating diversity to excel as a team
Social Media Palooza – Riding the digital wave while guarding your brand and reputation

To gain a view of the event brochure, click here: http://www.marcusevans-conferences-northamerican.com/IPLawEU_eaag_IPW

For speaking, sponsoring or attending, please contact Laurel Zevitz at +1 312-540-3000 ext 6683 or email l.zevitz@marcusevansch.com

Big Pharmaceutical Firms Say MDGs Partnerships Are ‘Best-Kept Secret’

NEW YORK – The vast collaboration between the pharmaceutical industry, government and civil society is perhaps “one of the best-kept secrets of our industry,” the head of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) said this week, stressing the need for even more cooperating heading into the post-2015 development agenda at the United Nations.